Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Therapeutic and Health Promoting Potential of Terminalia chebula: An Exploratory Literature Review

Author(s): Manisha Chopra, Geeta Deswal, Bhawna Chopra, Priyanka Kriplani, Rameshwar Dass, Ajmer Singh Grewal, Ashwani K. Dhingra* and Vaibhav Rathi

Volume 10, Issue 7, 2024

Published on: 04 September, 2023

Article ID: e150823219722 Pages: 13

DOI: 10.2174/2215083810666230815142547

Price: $65

conference banner
Abstract

The plant Terminalia chebula has been used traditionally in many regions of the world for its therapeutic properties, especially in India. Its therapeutic and health-promoting potential has been recognized for centuries, and modern research continues to unveil its numerous benefits. One of the most significant applications of this plant is its antimicrobial and antioxidant potential. The plant contains high levels of phenolic compounds and flavonoids, which scavenge harmful free radicals in the body, reducing oxidative stress and cellular damage. This antioxidant action contributes to its anti-inflammatory effects, making it beneficial for a wide range of conditions, including arthritis, cardiovascular diseases, and neurodegenerative disorders. Furthermore, Terminalia chebula exhibits antimicrobial activity against various bacteria and fungi, including those responsible for common infections. It has been used to treat respiratory infections, urinary tract infections, and skin ailments. Its broad-spectrum antimicrobial effects make it a valuable natural remedy for combating microbial pathogens. Moreover, Terminalia chebula shows potential in managing diabetes and promoting cardiovascular health. Studies have indicated its ability to regulate blood sugar levels, improve insulin sensitivity, and reduce lipid abnormalities. These properties make it a promising adjunct therapy for individuals with diabetes or at risk of heart disease. In conclusion, Terminalia chebula possesses remarkable therapeutic and health-promoting potential. Its antioxidant, anti-inflammatory, antimicrobial, and digestive benefits make it a valuable natural remedy for various ailments. While research on Terminalia chebula is ongoing, its long-standing use in traditional medicine and emerging scientific evidence solidify its status as a potent medicinal plant with diverse applications in promoting overall well-being.

Keywords: Terminalia chebula, antibacterial, anti-inflammatory, phytochemicals, pharmacology, medicinal plant.

Graphical Abstract

[1]
Nigam M, Mishra AP, Adhikari-Devkota A, et al. Fruits of Terminalia chebula Retz.: A review on traditional uses, bioactive chemical constituents and pharmacological activities. Phytother Res 2020; 34(10): 2518-33.
[http://dx.doi.org/10.1002/ptr.6702] [PMID: 32307775]
[2]
Anokwuru CP, Sandasi M, Chen W, et al. Investigating antimicrobial compounds in South African combretaceae species using a biochemometric approach. J Ethnopharmacol 2021; 269: 113681.
[http://dx.doi.org/10.1016/j.jep.2020.113681] [PMID: 33307052]
[3]
Dawe A, Pierre S, Tsala DE, Habtemariam S. Phytochemical constituents of Combretum Loefl. (Combretaceae). Pharm Crop 2013; 4(1): 38-59.
[http://dx.doi.org/10.2174/2210290601304010038]
[4]
Rahate S, Hemke A, Umekar M. Review on combretaceae family. Int J Pharm Sci Rev Res 2019; 58(2): 22-9.
[5]
Cock IE. The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacology 2015; 23(5): 203-29.
[http://dx.doi.org/10.1007/s10787-015-0246-z] [PMID: 26226895]
[6]
Bag A, Bhattacharyya SK, Chattopadhyay RR. The development of Terminalia chebula Retz. (Combretaceae) in clinical research. Asian Pac J Trop Biomed 2013; 3(3): 244-52.
[http://dx.doi.org/10.1016/S2221-1691(13)60059-3] [PMID: 23620847]
[7]
Wu G, Dong Z, Dong J, et al. Effects of mongolian medicine Terminalia chebula Retz. on 6 CYP450 enzymes in rats. Int J Clin Exp Pathol 2020; 13(12): 3128-38.
[PMID: 33425113]
[8]
Gupta PC. Biological and pharmacological properties of Terminalia chebula Retz.(Haritaki)-An overview. Int J Pharma Sci 2012; 4(3): 62-8.
[9]
Kumar R, Arora R, Agarwal A, Gupta YK. Protective effect of Terminalia chebula against seizures, seizure-induced cognitive impairment and oxidative stress in experimental models of seizures in rats. J Ethnopharmacol 2018; 215: 124-31.
[http://dx.doi.org/10.1016/j.jep.2017.12.008] [PMID: 29248452]
[10]
Ratha K, Joshi G. Haritaki (Chebulic myrobalan) and its varieties. Ayu 2013; 34(3): 331-4.
[http://dx.doi.org/10.4103/0974-8520.123139] [PMID: 24501534]
[11]
Hooker JD. Flora of british India. In: London: Oxford 1854.
[12]
Aamina M, Alhowail A, Aldubayan M, Rabbani SI. Terminalia chebula Retz: A prospective agent in reducing the doxorubicin-mediated cardiotoxicity. Pharmacognosy Res 2020; 12(3): 219.
[13]
Akhtar N, Khan AB, Muhammad S, et al. Formulation and characterization of a cream containing terminalia chebula extract. Forsch Komplement Med 2012; 19(1): 20-5.
[http://dx.doi.org/10.1159/000335823] [PMID: 22398922]
[14]
Tamhane MD, Thorat SP, Rege NN, Dahanukar SA. Effect of oral administration of Terminalia chebula on gastric emptying: An experimental study. J Postgrad Med 1997; 43(1): 12-3.
[PMID: 10740705]
[15]
Lee DY, Kim HW, Yang H, Sung SH. Hydrolyzable tannins from the fruits of Terminalia chebula Retz and their α-glucosidase inhibitory activities. Phytochemistry 2017; 137: 109-16.
[http://dx.doi.org/10.1016/j.phytochem.2017.02.006] [PMID: 28213992]
[16]
Juang LJ, Sheu SJ, Lin TC. Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J Sep Sci 2004; 27(9): 718-24.
[http://dx.doi.org/10.1002/jssc.200401741] [PMID: 15387468]
[17]
Nam YJ, Hwang YS. Antibacterial and antioxidant effect of ethanol extracts of Terminalia chebula on Streptococcus mutans. Clin Exp Dent Res 2021; 7(6): 987-94.
[http://dx.doi.org/10.1002/cre2.467] [PMID: 34184430]
[18]
Lee M, Hwang YS. Anticaries effect of ethanol extract of terminalia chebula. J Dent Hyg Sci 2021; 21(2): 119-26.
[http://dx.doi.org/10.17135/jdhs.2021.21.2.119]
[19]
Kumar V, Chandel SR, Guleria S, et al. Comparative analysis of phytochemicals, antimicrobial and antioxidant activity of different spe-cies of terminalia from himachal pradesh, India. Vegetos 2021; 34(3): 528-39.
[http://dx.doi.org/10.1007/s42535-021-00232-y]
[20]
Ankegowda VM, Kollur SP, Prasad SK, et al. Phyto-mediated synthesis of silver nanoparticles using Terminalia chebula fruit extract and evaluation of its cytotoxic and antimicrobial potential. Molecules 2020; 25(21): 5042.
[http://dx.doi.org/10.3390/molecules25215042] [PMID: 33143044]
[21]
Khatak S, Wadhwa N, Jain P. Efficacy of methanolic extract of fruit pulp and leaf of terminalia chebula and aeglesmarmelos against staphylococcus aureus. Biosci Biotechnol Res Commun 2020; 13(4): 2099-107.
[http://dx.doi.org/10.21786/bbrc/13.4/70]
[22]
Das G, Kim DY, Fan C, et al. Plants of the genus Terminalia: An insight on its biological potentials, pre-clinical and clinical studies. Front Pharmacol 2020; 11: 561248.
[http://dx.doi.org/10.3389/fphar.2020.561248] [PMID: 33132909]
[23]
Rathinamoorthy R, Thilagavathi G. Statistical optimization of Terminalia chebula fruit extraction for improved antibacterial activity against odour-causing bacteria. Proc Natl Acad Sci, India, Sect B Biol Sci 2020; 90(2): 365-74.
[http://dx.doi.org/10.1007/s40011-019-01105-w]
[24]
Li K, Han X, Li R, et al. Composition, antivirulence activity, and active property distribution of the fruit of Terminalia chebula Retz. J Food Sci 2019; 84(7): 1721-9.
[http://dx.doi.org/10.1111/1750-3841.14655] [PMID: 31206192]
[25]
Mandeville A, Cock IE. Terminalia chebula Retz. fruit extracts inhibit bacterial triggers of some autoimmune diseases and potentiate the activity of tetracycline. Indian J Microbiol 2018; 58(4): 496-506.
[http://dx.doi.org/10.1007/s12088-018-0754-9] [PMID: 30262960]
[26]
Thirunavukkarasu B, Purushothaman N. Antibacterial and synergistic activity of Terminalia chebula and Terminalia bellerica fruit extracts against ESBL producers. Int J Curr Pharm Res 2017; 9(6): 8-11.
[http://dx.doi.org/10.22159/ijcpr.2017v9i6.23419]
[27]
Asimuddin M, Ranawat B, Jamil K, Rao C. Estimation of Antibacterial Activity of Plants Extracts from Phyllanthus Emblica, Terminalia Chebula and Eucalyptus Globulus Against Oral Pathogens. Int J Dent Oral Health 2017; 3(9): 99-103.
[28]
Venkatesan A, Kathirvel A, Prakash S, Sujatha V. Antioxidant, antibacterial activities and identification of bioactive compounds from Terminalia chebula bark extracts. Free Radic Antioxid 2016; 7(1): 43-9.
[http://dx.doi.org/10.5530/fra.2017.1.7]
[29]
Singh P, Malhotra H. Terminalia chebula: A review pharmacognostic and phytochemical studies. Int J Recent Sci Res 2017; 8: 21496-507.
[30]
Revathi M, Senthilkumar G, Panneerselvam A, Karthy S, Gopika R. In vitro assessment of Terminalia chebula Retz. Fruits against methi-cillin resistant staphylococcus aureus. Int J Pharm Sci Res 2016; 10(6): 2670-87.
[31]
Grover S, Dixit A, Dixit S. Evaluation of Antibacterial Efficacy of Terminalia Chebula Fruit Extracts against Enterococcus Faecalis. An-nals of Prosthodontics and Restorative Dentistry 2016; 2(1): 1-4.
[32]
Dhiman R, Kumar Aggarwal N, Aneja KR, Kaur M, Kumar V. In vitro antimicrobial activity and phytochemical studies of Terminalia chebula against the microbes isolated from fruit juices. J Microbiol Biotechnol Food Sci 2015; 5(3): 243-7.
[http://dx.doi.org/10.15414/jmbfs.2015/16.5.3.243-247]
[33]
Ahuja C, Kaur H, Sharma R. Antibacterial activity of Terminalia Chebula fruit by agar well diffusion method. J Chem Environ Sci Appl 2015; 1(2): 67-72.
[34]
Baliah NT, Astalakshmi A. Phytochemical analysis and antibacterial activity of extracts from Terminalia chebula Retz. Int J Curr Microbiol Appl Sci 2014; 3(3): 992-9.
[35]
Nayak SS, Metgud SC, Bolmal UK, Bolmal UK. An In vitro study to determine the effect of Terminalia chebula extract and its formulation on Streptococcus mutans. J Contemp Dent Pract 2014; 15(3): 278-82.
[http://dx.doi.org/10.5005/jp-journals-10024-1528] [PMID: 25307806]
[36]
Rathinamoorthy R, Thilagavathi G. Terminalia chebula-review on pharmacological and biochemical studies. Int J Pharm Tech Res 2014; 6: 97-116.
[37]
Amala VE, Jeyaraj M. Phytochemical, antibacterial and functional group identification of medicinally useful plant Terminalia chebula retz., against Staphylococcus aureus, Psuedomonas aeruginosa and Klebsiella pneumonia. Indian J Appl Res 2014; 4: 23-5.
[http://dx.doi.org/10.15373/2249555X/JAN2014/8]
[38]
Bag A, Chattopadhyay RR. Efflux-pump inhibitory activity of a gallotannin from Terminalia chebula fruit against multidrug-resistant uropathogenic Escherichia coli. Nat Prod Res 2014; 28(16): 1280-3.
[http://dx.doi.org/10.1080/14786419.2014.895729] [PMID: 24620744]
[39]
Gautam MK, Ghatule RR, Singh A, Kumar M, Goel R. Healing effect of Terminalia chebula fruit extract on trinitrobenzene sulfonic acid induced colitis in rat. Indian J Physiol Pharmacol 2013; 57(3): 325-36.
[40]
Sharma C, Aneja KR, Kasera R, Aneja A. Antimicrobial potential of Terminalia chebula Retz. fruit extracts against ear pathogens. World J Otorhinolaryngol 2012; 2(2): 8-13.
[http://dx.doi.org/10.5319/wjo.v2.i2.8]
[41]
Singh D, Singh D, Choi SM, Zo SM, Ki SB, Han SS. Therapeutical effect of extracts of Terminalia chebula in inhibiting human pathogens and free radicals. Int J Biosci Biochem Bioinform 2012; 2(3): 164-7.
[http://dx.doi.org/10.7763/IJBBB.2012.V2.93]
[42]
Singh G, Kumar P. Evaluation of antimicrobial activity of alkaloids of Terminalia chebula Retz. against some multidrug-resistant micro-organisms. Intl J Green Pharm 2012; 6(1): 57-62.
[http://dx.doi.org/10.4103/0973-8258.97131]
[43]
Bag A, Bhattacharyya SK, Pal NK, Chattopadhyay RR. In vitro antimicrobial potential of Terminalia chebula fruit extracts against multi-drug-resistant uropathogens. Asian Pac J Trop Biomed 2012; 2(3): S1883-7.
[http://dx.doi.org/10.1016/S2221-1691(12)60514-0]
[44]
Sagar A, Parvez S. Antibacterial Activity of Terminalia chebula (Retz.), Emblica officinalis (Gaertn.) and Terminalia bellirica (Gaetn.) Roxb. J Pure Appl Microbiol 2012; 6(3): 1475-80.
[45]
Rathinamoorthy R, Udayakumar S, Thilagavathi G. Antibacterial efficacy analysis of Punica granatum L. leaf, rind and Terminalia chebula fruit extract treated cotton fabric against five most common human pathogenic bacteria. Int J Pharm Life Sci 2011; 2(10): 1147-9.
[46]
Lee D, Boo KH, Woo JK, et al. Anti-bacterial and anti-viral activities of extracts from Terminalia chebula barks. J Korean Soc Appl Biol Chem 2011; 54(2): 295-8.
[http://dx.doi.org/10.3839/jksabc.2011.046]
[47]
Li K, Diao Y, Zhang H, et al. Tannin extracts from immature fruits of Terminalia chebula Fructus Retz. promote cutaneous wound heal-ing in rats. BMC Complement Altern Med 2011; 11(1): 86.
[http://dx.doi.org/10.1186/1472-6882-11-86] [PMID: 21982053]
[48]
Kannan P, Ramadevi SR, Waheeta H. Antibacterial activity of Terminalia chebula fruit extract. Afr J Microbiol Res 2009; 3(4): 180-4.
[49]
Bag A, Bhattacharyya SK, Bharati P, Pal NK, Chattopadhyay RR. Evaluation of antibacterial properties of Chebulic myrobalan (fruit of Terminalia chebula Retz.) extracts against methicillin resistant Staphylococcus aureus and trimethoprim-sulphamethoxazole resistant uropathogenic Escherichia coli. Afr J Plant Sci 2009; 3(2): 25-9.
[50]
Shinde SL, Junne SB, Wadje SS, Baig MMV. The diversity of antibacterial compounds of Terminalia species (Combretaceae). Pak J Biol Sci 2009; 12(22): 1483-6.
[http://dx.doi.org/10.3923/pjbs.2009.1483.1486] [PMID: 20180323]
[51]
Acharyya S, Patra A, Bag PK. Evaluation of the antimicrobial activity of some medicinal plants against enteric bacteria with particular reference to multi-drug resistant Vibrio cholerae. Trop J Pharm Res 2009; 8(3): 231-7.
[http://dx.doi.org/10.4314/tjpr.v8i3.44538]
[52]
Rai AK, Joshi R. Evaluation of antimicrobial properties of fruit extracts of Terminalia chebula against dental caries pathogens. Jundishapur J Microbiol 2009; 2(3): 105-11.
[53]
Kumar MS, Kirubanandan S, Sripriya R, Sehgal PK. Triphala promotes healing of infected full-thickness dermal wound. J Surg Res 2008; 144(1): 94-101.
[http://dx.doi.org/10.1016/j.jss.2007.02.049] [PMID: 17662304]
[54]
Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell RR. Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. Int J Antimicrob Agents 2001; 18(1): 85-8.
[http://dx.doi.org/10.1016/S0924-8579(01)00352-1] [PMID: 11463533]
[55]
Sato Y, Oketani H, Singyouchi K, et al. Extraction and purification of effective antimicrobial constituents of Terminalia chebula RETS. against methicillin-resistant Staphylococcus aureus. Biol Pharm Bull 1997; 20(4): 401-4.
[http://dx.doi.org/10.1248/bpb.20.401] [PMID: 9145218]
[56]
Kalidindi SR. Terminalia chebula and terminalia bellerica extracts for inhibition of xanthine oxidase. Patent CA2859099A1, 2015.
[57]
Ravindran D, Kumar RR, Ramadas K, Pillai MR. Mouthwash composition for managing oral mucositis, process and methods thereof. Patent US20130243702A1, 2013.
[58]
Mitra SK, Suriyanarayanan R, Babu UD, Saxena E. Herbal dental care composition, method of manufacturing the same and use thereof. Patent US8114448B2, 2012.
[59]
Palpu P, Venkateswara RC, Raghavan G, et al. Anti-arthritic herbal composition and method thereof. Patent US7618663B2, 2009.
[60]
Palpu P, Pal M, Dixit BS, Banerji R, Rao CV. Herbal dye and process of preparation thereof. Patent US7186279B2, 2007.
[61]
Parikh MB. Herbal composition for havan (yagna) tablet for combustion for medicinal and odoriferous treatment of humans, animals and plants Patent WO2007072500A2, 2007.
[62]
Doshi M, Vasavada S, Joshi M, Mody S. Herbal cough formulations and process for the preparation thereof. Patent US20030228383A1, 2003.
[63]
Jung HL, Yang SY, Pyo MC, et al. Protective effects of chebulic acid from Terminalia chebula Retz. against t-BHP-induced oxidative stress by modulations of Nrf2 and its related enzymes in HepG2 cells. Food Sci Biotechnol 2019; 28(2): 555-62.
[http://dx.doi.org/10.1007/s10068-018-0477-z] [PMID: 30956868]
[64]
Saha S, Verma RJ. Antioxidant activity of polyphenolic extract of Terminalia chebula Retzius fruits. J Taibah Univ Sci 2016; 10(6): 805-12.
[http://dx.doi.org/10.1016/j.jtusci.2014.09.003]
[65]
Chang CL, Lin CS. Phytochemical composition, antioxidant activity, and neuroprotective effect of Terminalia chebulaRetzius extracts. Evid Based Complement Alternat Med 2012; 2012: 1-7.
[http://dx.doi.org/10.1155/2012/125247] [PMID: 21754945]
[66]
Zhao L, Duan Z, Wang Y, et al. Protective effect of Terminalia chebula Retz. extract against Aβ aggregation and Aβ-induced toxicity in Caenorhabditis elegans. J Ethnopharmacol 2021; 268: 113640.
[http://dx.doi.org/10.1016/j.jep.2020.113640] [PMID: 33307058]
[67]
Wang W, Yang L, Liu T, et al. Corilagin ameliorates sleep deprivation-induced memory impairments by inhibiting NOX2 and activating Nrf2. Brain Res Bull 2020; 160: 141-9.
[http://dx.doi.org/10.1016/j.brainresbull.2020.03.010] [PMID: 32389388]
[68]
Suryavanshi SV, Garud MS, Barve K, Addepalli V, Utpat SV, Kulkarni YA. Triphala ameliorates nephropathy via inhibition of TGF-β1 and oxidative stress in diabetic rats. Pharmacology 2020; 105(11-12): 681-91.
[http://dx.doi.org/10.1159/000508238] [PMID: 32674108]
[69]
Kalra P, Karwasra R, Gupta YK, Ray SB, Singh S. Terminalia chebula supplementation attenuates cisplatin-induced nephrotoxicity in Wistar rats through modulation of apoptotic pathway. Nat Prod Res 2019; 33(11): 1641-5.
[http://dx.doi.org/10.1080/14786419.2018.1425843] [PMID: 29343091]
[70]
Sultana S, Majed F, Nafees S, et al. Terminalia chebula attenuates DMBA/Croton Oil-Induced oxidative stress and inflammation in Swiss albino mouse skin. Toxicol Int 2015; 22(1): 21-9.
[http://dx.doi.org/10.4103/0971-6580.172252] [PMID: 26862256]
[71]
Rubini B, Shanthi G, Soundhari C, Rajarajan S. Antifungal activity of terminalia chebula and terminalia catappa on two dermatophytes. J Med Aroma Plants 2013; 4(2): 15-9.
[72]
Mangala S, Latha C. Antiviral and antioxidant activities of two medicinal plants. Int J Curr Sci 2012; 256-61.
[73]
Mishra N, Kesharwani A, Agarwal A, Polachira S, Nair R, Gupta S. Herbal gel formulation developed for anti-human immunodeficiency virus (HIV)-1 activity also inhibits In vitro HSV-2 infection. Viruses 2018; 10(11): 580.
[http://dx.doi.org/10.3390/v10110580] [PMID: 30352961]
[74]
Kumar CU, Pokuri VK, Pingali U. Evaluation of the analgesic activity of standardized aqueous extract of Terminalia chebula in healthy human participants using hot air pain model. J Clin Diagn Res 2015; 9(5): FC01-4.
[http://dx.doi.org/10.7860/JCDR/2015/11369.5916] [PMID: 26155489]
[75]
Seo JB, Jeong JY, Park JY, et al. Anti-arthritic and analgesic effect of NDI10218, a standardized extract of Terminalia chebula, on arthri-tis and pain model. Biomol Ther (Seoul) 2012; 20(1): 104-12.
[http://dx.doi.org/10.4062/biomolther.2012.20.1.104] [PMID: 24116282]
[76]
Ahmed S, Ding X, Sharma A. Exploring scientific validation of Triphala Rasayana in Ayurveda as a source of rejuvenation for contem-porary healthcare: An update. J Ethnopharmacol 2021; 273: 113829.
[http://dx.doi.org/10.1016/j.jep.2021.113829] [PMID: 33465446]
[77]
Sonarkar SS, Bhadoria N, Gunwal MK, Suryawanshi H. Antiadherence and antimicrobial property of herbal extracts (Glycyrrhiza glabra and Terminalia chebula ) on Streptococcus mutans: An in vitro experimental study. J Oral Maxillofac Pathol 2019; 23(1): 73-7.
[http://dx.doi.org/10.4103/jomfp.JOMFP_103_18] [PMID: 31110420]
[78]
Shendge AK, Sarkar R, Mandal N. Potent anti‐inflammatory Terminalia chebula fruit showed in vitro anticancer activity on lung and breast carcinoma cells through the regulation of Bax/Bcl‐2 and caspase‐cascade pathways. J Food Biochem 2020; 44(12): e13521.
[http://dx.doi.org/10.1111/jfbc.13521] [PMID: 33043490]
[79]
Liu F, Liu Y, Zhan S, et al. Chebulanin exerts its anti-inflammatory and antiarthritic effects via inhibiting NF-κB and MAPK activation in collagen-induced arthritis mice. Int Immunopharmacol 2020; 88: 106823.
[http://dx.doi.org/10.1016/j.intimp.2020.106823] [PMID: 32795901]
[80]
Bag PK, Roy N, Acharyya S, et al. In vivo fluid accumulation-inhibitory, anticolonization and anti-inflammatory and In vitro biofilm-inhibitory activities of methyl gallate isolated from Terminalia chebula against fluoroquinolones resistant Vibrio cholerae. Microb Pathog 2019; 128: 41-6.
[http://dx.doi.org/10.1016/j.micpath.2018.12.037] [PMID: 30578837]
[81]
Khare B, Shukla TP. a review on polyherbal formulation used in the treatment of rheumatoid arthritis. Int J Adv Sci Res 2022; 13(01): 31-42.
[82]
Akram N, Srivastava M, Mishra MK. Antidiabetic activity of root of Terminalia chebula on alloxan induced diabetic rat. World Journal of Pharmaceutical and Medical Research 2019; 5(3): 108-12.
[83]
Kim HL, Choi BK, Yang SH. Terminalia chebula medicinal uses: A review of in vitro and in vivo studies. Biotechnol Bioprocess Eng 2022; 27(5): 729-39.
[http://dx.doi.org/10.1007/s12257-022-0090-0]
[84]
Pingali U, Sukumaran D, Nutalapati C. Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflam-mation, and lipid profile in type 2 diabetes mellitus: A randomized double‐blind, placebo‐controlled clinical study. Phytother Res 2020; 34(12): 3226-35.
[http://dx.doi.org/10.1002/ptr.6771] [PMID: 32618037]
[85]
Peterson CT, Pourang A, Dhaliwal S, et al. Modulatory effects of triphala and manjistha dietary supplementation on human gut microbiota: A double-blind, randomized, placebo-controlled pilot study. J Altern Complement Med 2020; 26(11): 1015-24.
[http://dx.doi.org/10.1089/acm.2020.0148] [PMID: 32955913]
[86]
Agarwal N, Chaturvedi Y, Mishra P, Chaturvedi Y, Suohu T. Comparison of Punica granatum, Terminalia chebula, and Vitis vinifera seed extracts used as Mouth rinse on salivary Streptococcus mutans levels in children. J Contemp Dent Pract 2019; 20(8): 920-7.
[http://dx.doi.org/10.5005/jp-journals-10024-2617] [PMID: 31797848]
[87]
Karlapudi V, Prasad Mungara AVV, Sengupta K, Davis BA, Raychaudhuri SP. A placebo-controlled double-blind study demonstrates the clinical efficacy of a novel herbal formulation for relieving joint discomfort in human subjects with osteoarthritis of knee. J Med Food 2018; 21(5): 511-20.
[http://dx.doi.org/10.1089/jmf.2017.0065] [PMID: 29708818]
[88]
Lopez HL, Habowski SM, Sandrock JE, et al. Effects of dietary supplementation with a standardized aqueous extract of Terminalia chebula fruit (AyuFlex®) on joint mobility, comfort, and functional capacity in healthy overweight subjects: A randomized placebo-controlled clinical trial. BMC Complement Altern Med 2017; 17(1): 475.
[http://dx.doi.org/10.1186/s12906-017-1977-8] [PMID: 28969626]
[89]
Usharani P, Nutalapati C, Pokuri VK, Kumar U, Taduri G. A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia. Clin Pharmacol 2016; 8: 51-9.
[http://dx.doi.org/10.2147/CPAA.S100521] [PMID: 27382337]

Rights & Permissions Print Cite
Article Metrics
16
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy